Immunovia AB (publ) (IMMNOV.ST)
IMMNOV.ST Stock Price Chart
Explore Immunovia AB (publ) interactive price chart. Choose custom timeframes to analyze IMMNOV.ST price movements and trends.
IMMNOV.ST Company Profile
Discover essential business fundamentals and corporate details for Immunovia AB (publ) (IMMNOV.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
1 Dec 2015
Employees
9.00
Website
https://www.immunovia.comCEO
Jeff Borcherding
Description
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
IMMNOV.ST Financial Timeline
Browse a chronological timeline of Immunovia AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 19 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 14 May 2025
EPS came in at -kr 0.24 falling short of the estimated -kr 0.12 by -100.00%, while revenue for the quarter reached kr 139.00K , missing expectations by -86.10%.
Earnings released on 25 Feb 2025
EPS came in at kr 0.02 , while revenue for the quarter reached kr 455.00K .
Earnings released on 27 Nov 2024
EPS came in at -kr 1.13 , while revenue for the quarter reached kr 235.00K .
Earnings released on 5 Aug 2024
EPS came in at -kr 0.57 , while revenue for the quarter reached kr 85.00K .
Earnings released on 29 Apr 2024
EPS came in at -kr 0.07 , while revenue for the quarter reached kr 156.00K .
Earnings released on 21 Feb 2024
EPS came in at -kr 1.08 , while revenue for the quarter reached kr 156.00K .
Earnings released on 9 Nov 2023
EPS came in at -kr 0.91 , while revenue for the quarter reached kr 488.00K .
Earnings released on 30 Aug 2023
EPS came in at -kr 4.00 , while revenue for the quarter reached kr 412.00K .
Earnings released on 23 May 2023
EPS came in at -kr 2.40 , while revenue for the quarter reached kr 520.00K .
Stock split effective on 20 Mar 2023
Shares were split 1077 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 23 Feb 2023
EPS came in at -kr 3.43 , while revenue for the quarter reached kr 502.00K , missing expectations by -74.90%.
Earnings released on 10 Nov 2022
EPS came in at -kr 0.16 , while revenue for the quarter reached kr 358.00K , missing expectations by -55.25%.
Earnings released on 24 Aug 2022
EPS came in at -kr 0.68 , while revenue for the quarter reached kr 103.00K , missing expectations by -79.40%.
Earnings released on 28 Apr 2022
EPS came in at -kr 1.68 , while revenue for the quarter reached kr 182.00K .
Earnings released on 17 Feb 2022
EPS came in at -kr 2.08 , while revenue for the quarter reached kr 305.00K , missing expectations by -94.45%.
Earnings released on 11 Nov 2021
EPS came in at -kr 1.48 , while revenue for the quarter reached kr 377.00K .
Earnings released on 19 Aug 2021
EPS came in at -kr 2.02 , while revenue for the quarter reached kr 38.00K .
Earnings released on 28 Apr 2021
EPS came in at -kr 0.96 , while revenue for the quarter reached kr 123.00K .
Earnings released on 17 Feb 2021
EPS came in at -kr 2.04 , while revenue for the quarter reached kr 152.00K .
Earnings released on 12 Nov 2020
EPS came in at -kr 1.56 , while revenue for the quarter reached kr 37.00K .
IMMNOV.ST Stock Performance
Access detailed IMMNOV.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.